Hangzhou Diagens Biotechnology (2526 HK)

Hangzhou Diagens Biotechnology develops AI-driven medical imaging products and services, including the AI AutoVision chromosome karyotype analysis system, MetaSight automatic cell microscopic image scanning system, and the iMed MaaS medical imaging AI platform. The company also offers KayoFlow automatic cell harvesters and related laboratory reagents and consumables. It was founded in 2016 and is headquartered in Hangzhou, China.